Blood Culture Improvement Guidelines and Diagnostic Stewardship for Antibiotic Reduction in Critically Ill Children

CompletedOBSERVATIONAL
Enrollment

15

Participants

Timeline

Start Date

April 1, 2018

Primary Completion Date

December 28, 2021

Study Completion Date

December 28, 2021

Conditions
SepsisBacteremia
Interventions
OTHER

Multicenter Quality Improvement program

Participating institutions will not participate in an intervention study. Sites will design and implement local QI programs to improve care within their unit. Local healthcare teams, who are interested in directly and immediately improving patient outcomes, will devise customized tools. The Bright STAR Team will assess the impact of these local QI initiatives on patient health outcomes, using data that are collected as part of the QI programs or through routine clinical care.

Trial Locations (5)

44106

Rainbow Babies & Children's Hospital, Cleveland

63110

St. Louis Children's Hospital, Washington University, St Louis

78723

Dell Children's Medical Center of Central Texas, Austin

97239

OHSU Doernbecher Children's Hospital, Portland

98105

Seattle Children's Hospital, Seattle

All Listed Sponsors
lead

Johns Hopkins University

OTHER

NCT03441126 - Blood Culture Improvement Guidelines and Diagnostic Stewardship for Antibiotic Reduction in Critically Ill Children | Biotech Hunter | Biotech Hunter